Anti-obesity of probiotics is related to improvements in lipid metabolism, insulin sensitivity, anti-inflammation, or control of intestinal hormones like leptin or GLP-1, which is frequently accompanied by modulating the intestinal microbiota [39,40,41]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.